Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transglutaminase 2 function in glioblastoma tumor efferocytosis.

Cell death & disease·2025
Same author

Potential roles for efferocytosis in glioblastoma immune evasion.

Neuro-oncology advances·2024
Same author

Engineered cells as glioblastoma therapeutics.

Cancer gene therapy·2021
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.4K

Modeling glioblastoma.

Ian Lorimer1,2

  • 1Ottawa Hospital Research Institute, Ottawa, Canada.

Elife
|July 25, 2024
PubMed
Summary
This summary is machine-generated.

Researchers developed a zebrafish model for a deadly brain tumor, revealing the immune system

Keywords:
cancercancer biologycancer variant modelingcell biologyglioblastomainflammationtumor microenvironmentzebrafish

More Related Videos

A 3D Spheroid Model for Glioblastoma
07:40

A 3D Spheroid Model for Glioblastoma

Published on: April 9, 2020

14.9K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

2.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.4K
A 3D Spheroid Model for Glioblastoma
07:40

A 3D Spheroid Model for Glioblastoma

Published on: April 9, 2020

14.9K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

2.7K

Area of Science:

  • Neuro-oncology
  • Immunology
  • Zebrafish Models

Background:

  • A novel zebrafish model was created to study a lethal form of brain cancer.
  • This model allows for the investigation of early-stage tumor development.

Discussion:

  • The study underscores the critical involvement of the immune system in the initial phases of brain tumor formation.
  • Investigating immune responses in early tumorigenesis is crucial for understanding disease progression.

Key Insights:

  • The zebrafish model successfully recapitulates key aspects of human brain tumor development.
  • Early immune cell activity is a significant factor in the initiation of this brain tumor type.

Outlook:

  • This model provides a platform for screening potential immunotherapies for brain tumors.
  • Further research will explore specific immune pathways involved in early tumorigenesis.